IMNN
Imunon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.34
−2.90%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.61
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.54
- EPS estimate
- -$0.87
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +27.8%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.87 | -$0.54 | Beat 37.75% | — |
| May 12, 2026 | -$1.22 | -$0.84 | Beat 30.86% | — |
| Mar 31, 2026 | -$1.43 | -$1.29 | Beat 9.79% | — |
| Nov 13, 2025 | -$1.73 | -$1.16 | Beat 32.95% | — |
| Feb 27, 2025 | -$0.36 | -$0.23 | Beat 36.11% | — |
| Nov 7, 2024 | -$0.37 | -$0.34 | Beat 8.11% | — |
| Aug 14, 2024 | -$0.55 | -$0.51 | Beat 7.27% | — |
| Nov 14, 2023 | -$0.66 | -$0.37 | Beat 43.94% | — |
| Aug 10, 2023 | -$0.71 | -$0.61 | Beat 14.08% | — |
| May 11, 2023 | -$0.69 | -$0.68 | Beat 1.45% | — |
| Nov 14, 2022 | -$0.81 | -$0.87 | Miss -7.41% | $125.0K |
| Aug 15, 2022 | -$1.12 | -$0.87 | Beat 22.32% | $125.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026